Influence of Intravenous Magnesium Sulfate Infusion on the Subjective Postoperative Quality of Recovery: A Meta-Analysis of Randomized Controlled Trials.

This meta-analysis investigated the effects of intravenous magnesium sulfate on the postoperative recovery quality, as assessed using the Quality of Recovery (QoR) questionnaire, in adult surgical patients. Seven randomized controlled trials involving 622 patients were included. Compared with the placebo, magnesium sulfate significantly improved the global QoR score on postoperative day 1 (standardized mean difference [SMD]: 1.24; 95% confidence interval: 0.70-1.78; < 0.00001). It also enhanced specific QoR dimensions, with substantial effects on pain (SMD: 1, < 0.00001) and physical comfort (SMD: 0.85, < 0.0001), a moderate effect on emotional state (SMD: 0.65, = 0.002), and small improvements in physical independence (SMD: 0.43, < 0.00001) and psychological support (SMD: 0.37, < 0.0001). In addition, magnesium sulfate reduced the intraoperative opioid consumption (SMD: -0.66, < 0.0001), postoperative pain severity, and the incidence of postoperative nausea and vomiting (risk ratio: 0.48, = 0.008). The extubation times were unaffected, whereas the post-anesthesia care unit stay was slightly prolonged. These findings highlight the potential of magnesium sulfate as a valuable adjunct for multimodal analgesia and enhanced recovery. Future studies should aim to elucidate the optimal dosing strategies, timing of administration, and specific surgical populations that may derive maximum benefits.